glp-1 metformin RA initiation versus and risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation The dual impact of GLP-1
Description
Lillys oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
Liu, J., Huan, Y., Li, C., Liu, M., and Shen, Z
Collagen Peptides : Rebuilds skin and joint health, improves flexibility
At the completion of the study, changes in HbA 1c from baseline in the sitagliptin group were 0.7% and 0.9% in the glipizide group ( P value not reported)
These results from longer trials with tirzepatide have elevated the performance standard for drug therapy directed at T2D and obesity
